MSME (Udyam registered) Ministry of MSME
- Category
- Small (2024-25)
- Udyam number
- UDYAM-MH-18-0029165
Invent Bio-Med Private Limited - healthcare in Mumbai, Maharashtra, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹20.39 Cr
▲ 37% YoY
Net profit · FY 2025
₹2.29 Cr
Net margin 11.2%
EBITDA · FY 2025
₹4.6 Cr
EBITDA margin 22.6%
Authorised capital
₹30 Cr
Registered with MCA
Paid-up capital
₹24.7 Cr
Issued & subscribed
Open charges
₹8.5 Cr
Satisfied ₹25.08 Cr
Company age
21 yrs
Est. 2005
Employees · EPFO
61
Provident fund records
About Invent Bio-Med Private Limited
Data last updated:
Invent Bio-Med Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the medical and laboratory equipment segment of the healthcare sector. It was incorporated on 03 May 2005 and has been in existence for over 21 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U33110MH2005PTC152988. Its GSTIN is 27AABCI3632E1ZX (Maharashtra). The company holds 5 GST registrations, all of them active.
The company has an authorised share capital of ₹30 Cr and a paid-up capital of ₹24.7 Cr. It is led by directors including Rajkumar Gopilal Manglunia and Amit Banwarilal Agrawal.
Its last annual general meeting (AGM) was held on 29 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 24 1st Floor Piramal Industrial Estate, Bldg No – 4 Piramal Nagar S.V. Road Goregaon (West) Mumbai – 400104, Maharashtra, India – 400104.
As per the financials filed for FY 2025, the company reported a revenue of ₹20.39 Cr, a growth of 37% compared to the previous year. For the same year it recorded a net profit of ₹2.29 Cr (net margin 11.2%) and EBITDA of ₹4.6 Cr (EBITDA margin 22.6%). Revenue has grown at a compounded annual rate (CAGR) of 90% over three years and 29% over five years.
The company has about 61 employees on its provident fund (EPFO) records.
The company is associated with 2 brands: Invent Bio and Invent Biomed. As per MCA filings, the company has open charges of ₹8.5 Cr and satisfied charges of ₹25.08 Cr on record. Court records list 33 cases involving the company, including 4 filed by the company and 30 filed against it; 6 cases are pending. The company has 18 deals on record (10 funding rounds, 6 secondary share transfers, 2 convertible or debt financings), with disclosed funding of ₹30.79 Cr; the latest was in September 2022. Its 4 peer companies in the Healthcare industry (Medical and Laboratory Equipment), with the same principal business activity (other manufacturing including jewellery, musical instruments, medical instruments, sports goods, etc. activities) are compared by revenue, 3 larger and 1 smaller; the largest is Aj Fibertek India Private Limited with revenue of ₹20.63 Cr. The company has 13 MSME Form 1 returns on record between 2017 and 2021, listing 49 overdue payments to 3 micro and small suppliers.
Invent Bio-Med Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-18-0029165). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website inventbiomed.com.
Company details
CIN U33110MH2005PTC152988
Registration Number 152988
Incorporation Date 03 May 2005
ROC Mumbai
Listing Status Unlisted
Company Status Active
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-MH-18-0029165
Key People
Rajkumar Gopilal Manglunia Director Amit Banwarilal Agrawal Director Ronak Manglunia Director Recognitions & Rankings of Invent Bio-Med
Contact details
Invent Bio-Med Private Limited's registered office is in Mumbai, Maharashtra. Its website is inventbiomed.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered Address24 1st Floor Piramal Industrial Estate, Bldg No – 4 Piramal Nagar S.V. Road Goregaon (West) Mumbai – 400104, Maharashtra, India – 400104
- IndustryHealthcare, Medical & Laboratory Equipment
To see the full contact details of Invent Bio-Med Private Limited, buy the company report.
Comprehensive company report
Invent Bio-Med Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Invent Bio-Med operates two associated brands: Invent Bio and Invent Biomed. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Provides a portfolio of interventional cardiovascular medical devices. | inventbio-med.com | |
| Manufacturer of drug eluting stents, PTCA balloon catheters, and vascular accessories | inventbiomed.com |
Business activity
The main business activity of Invent Bio-Med is manufacturing. In detail, this covers other manufacturing including jewellery, musical instruments, medical instruments, sports goods, etc. activities.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C13 | Other manufacturing including jewellery, musical instruments, medical instruments, sports goods, etc. activities |
To see the full business activity and turnover split of Invent Bio-Med Private Limited, buy the company report.
Financials of Invent Bio-Med Private Limited
FY 2025 filings availableInvent Bio-Med Private Limited reported revenue of ₹20.39 Cr (up 37% YoY) for FY 2025.
Revenue · FY 2025
₹20.39 Cr ▲ 37%
Net profit · FY 2025
₹2.29 Cr margin 11.2%
EBITDA · FY 2025
₹4.6 Cr margin 22.6%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 37%
3 years · compounded
▲ 90%
5 years · compounded
▲ 29%
EBITDA CAGR growth
1 year
▲ 405%
3 years · compounded
▲ 81%
5 years · compounded
▲ 63%
Revenue has grown at a compounded annual rate (CAGR) of 29% over five years, including 37% growth in the latest year. EBITDA rose 405% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹4.6 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹2.29 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 22.6% | ||||
| Net Profit Margin | 11.2% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Invent Bio-Med Private Limited, buy the company report.
Board of directors of Invent Bio-Med Private Limited
Invent Bio-Med has 4 current directors and 9 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rajkumar Gopilal Manglunia Also directs: Mohini Organics Private Limited | Director | 08 Aug 2017 | 9 Years 3 Months | Current |
| Amit Banwarilal Agrawal | Director | 16 May 2022 | 4 Years 5 Months | Current |
| Ronak Manglunia Also directs: Rajal Bindal Multisolutions Private Limited | Director | 08 Aug 2017 | 9 Years 3 Months | Current |
| Shyam Manglunia | Director | 08 Aug 2017 | 9 Years 3 Months | Current |
Peer comparison
Invent Bio-Med Private Limited is compared with the 4 companies closest to it by revenue in the Healthcare industry (Medical and Laboratory Equipment), with the same principal business activity (other manufacturing including jewellery, musical instruments, medical instruments, sports goods, etc. activities), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Aj Fibertek India Private Limited | ₹20.63 Cr (FY 2024) | 35.0% | Pune, Maharashtra, India | |||
| Advansys (India) Private Limited | ₹20.42 Cr (FY 2025) | 38.0% | Mumbai, Maharashtra, India | |||
| Infinity Mediquip India Private Limited | ₹20.4 Cr (FY 2024) | -1.0% | Delhi, India | |||
| Invent Bio-Med Private Limitedthis company | ₹20.39 Cr (FY 2025) | ₹2.29 Cr | 11.2% | 37.0% | 61 | Mumbai, Maharashtra, India |
| Dantech Digital Dental Solutions Private Limited | ₹20.14 Cr (FY 2025) | 357.0% | Chennai, Tamil Nadu, India |
To see the full peer comparison of Invent Bio-Med Private Limited, buy the company report.
Auditor
Invent Bio-Med Private Limited is audited by Mandhania & Associates for the financial year 2022.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Mandhania & Associates | FY 2022 | 114942W |
Shareholding
The shareholding of Invent Bio-Med Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Invent Bio-Med Private Limited, buy the company report.
Charges & borrowings
Open charges
₹8.5 Cr
Satisfied charges
₹25.08 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 05 Sep 2025 | 101176822 | Others | ₹8.5 Cr | Open | |
| 12 Jun 2012 | 10363011 | Punjab National Bank | ₹9.1 Cr | Satisfied | |
| 27 Jan 2012 | 10340899 | Small Industries Development Bank of India | ₹35 Lakh | Satisfied | |
| 07 Jul 2011 | 10295453 | Punjab National Bank | ₹7.23 Cr | Satisfied | |
| 26 Mar 2008 | 10110653 | Punjab National Bank | ₹6.3 Cr | Satisfied |
To see the full charge records of Invent Bio-Med Private Limited, buy the company report.
Total charge records: 7 View all charges
Deals & funding
Invent Bio-Med Private Limited has 18 deals on record (10 funding rounds, 6 secondary share transfers, 2 convertible or debt financings), with disclosed funding of ₹30.79 Cr; the latest was in September 2022.
Total deals
18
Funding rounds
10
Secondary share transfers
6
Convertible or debt financings
2
Disclosed funding
₹30.79 Cr
Deals on record (5 of 18)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Feb 2021 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: an individual |
| Feb 2020 | Funding round | ₹3.85 Cr | Investors: Anveshan Multisolutions LLP , 3 individuals |
| Sep 2018 | Secondary share transfer | Undisclosed | Buyer: 3 individuals Seller: 2 individuals |
| Mar 2017 | Secondary share transfer | Undisclosed | Buyer: Anmol Insurance Consultants Private Limited Seller: Ladderup Finance Limited |
| Dec 2007 | Funding round | ₹11 Lakh | Investors: Ladderup Finance Limited |
To see the full deal history of Invent Bio-Med Private Limited, buy the company report.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Invent Bio-Med Private Limited has 33 court cases on record: 4 filed by Invent Bio-Med, 30 filed against it. 6 cases are pending and 27 are disposed.
Total cases
33
Filed by the company
4
Filed against the company
30
Pending
6
Disposed
27
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 23 | 20 | 4 |
| NCLAT | 7 | 7 | 0 |
| High courts | 1 | 1 | 1 |
| Supreme Court | 1 | 1 | 1 |
| NCLT | 1 | 1 | 0 |
Cases on record (5 of 33)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Mumbai CMM Courts, Maharashtra | Court case (Summons Private cases SS) | Filed by the company against Zoomex Therapeutics Pvt. Ltd. and 3 others | Disposed |
| NCLAT, NCLAT New Delhi | Company appeal | Filed against the company by Invent Bio-Med Private Limited and 17 others | Disposed |
| NCLAT, NCLAT New Delhi | Company appeal | Filed by the company against Invent Bio-Med Private Limited and 5 others | Disposed |
| District court, Calcutta, West Bengal | Civil suit | Filed against the company by Magma Fincorp Limited | Disposed |
| Supreme Court | Court case | Filed against the company by an individual | Pending |
To see the full case history of Invent Bio-Med Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
Invent Bio-Med Private Limited has 13 MSME Form 1 returns on record between 2017 and 2021, listing 49 overdue payments to 3 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (3 of 3)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| Day Engineering Works | |||
| an individual supplier | |||
| Konark Fixtures Limited |
To see the full MSME payment records of Invent Bio-Med Private Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Employees & EPFO
Invent Bio-Med Private Limited has a workforce of 61 employees on its EPFO records as of May 2026, across 2 active EPFO establishments.
Employee count
61
Active EPFO establishments
2
Employee growth
-3.2%
Headcount by financial year
| Financial year | Employees (EPFO) |
|---|---|
| FY 2026-27 | 61 |
| FY 2025-26 | |
| FY 2024-25 | |
| FY 2023-24 | |
| FY 2022-23 | |
| FY 2021-22 | |
| FY 2020-21 | |
| FY 2019-20 | |
| FY 2018-19 | |
| FY 2017-18 | |
| FY 2016-17 |
To see the full employee and EPFO history of Invent Bio-Med Private Limited, buy the company report.
GST
Invent Bio-Med has 5 GST registrations: 5 active. The first 4 active GSTINs are listed below.
Total GSTINs
5
Active
5
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AABCI3632E1ZX | Maharashtra | Active | 01 Jul 2017 |
| 24AABCI3632E1Z3 | Gujarat | Active | 01 Jul 2017 |
| 24AABCI3632E2Z2 | Gujarat | Active | 13 Sep 2017 |
| 29AABCI3632E1ZT | Karnataka | Active | 19 Mar 2020 |
To see the full GST registrations and return filing status of Invent Bio-Med Private Limited, buy the company report.
Recent activity
Invent Bio-Med Private Limited has 13 board changes on record since 2010: 4 appointments and 9 cessations. The latest: Amit Banwarilal Agrawal ceased to be Additional Director on 30 Sep 2022.
AGM
Invent Bio-Med Private Limited last Annual general meeting of members was held on 29 Sep 2025 as per latest MCA records.
Charges
A charge with Others amounted to Rs. 8.50 Cr with Charge ID 101176822 was registered on 05 Sep 2025.
Filing
Invent Bio-Med Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai.
Ceased
Amit Banwarilal Agrawal ceased to be Additional Director.
Appointed
Amit Banwarilal Agrawal was appointed as Director.
Charges
A charge registered on 12 Jun 2012 via Charge ID 10363011 with Punjab National Bank was fully satisfied on 11 Oct 2019.
Charges
A charge registered on 07 Jul 2011 via Charge ID 10295453 with Punjab National Bank was fully satisfied on 11 Oct 2019.
Charges
A charge registered on 26 Mar 2008 via Charge ID 10110653 with Punjab National Bank was fully satisfied on 11 Oct 2019.
Charges
A charge registered on 27 Jan 2012 via Charge ID 10340899 with Small Industries Development Bank Of India was fully satisfied on 05 Sep 2019.
Ceased
Nivedita Ravishankar Srivastava ceased to be Whole-Time Director.
Ceased
Ravishankar Srivastava ceased to be Managing Director.
Ceased
Rajkumar Gopilal Manglunia ceased to be Additional Director.
21 earlier events are in the company report.
Frequently asked questions
Invent Bio-Med is an active private limited company based in Mumbai, Maharashtra, India. The company works in medical and laboratory equipment, within the healthcare industry. It was incorporated on 03 May 2005 (21+ years old) and is registered under CIN U33110MH2005PTC152988.
Invent Bio-Med has 4 current directors:
- Rajkumar Gopilal Manglunia - Director
- Amit Banwarilal Agrawal - Director
- Ronak Manglunia - Director
- Shyam Manglunia - Director
The latest financial statements of Invent Bio-Med on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 29 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Invent Bio-Med is 27AABCI3632E1ZX, registered in Maharashtra. The company has 5 GST registrations in all, of which 5 are active. Other active GSTINs include 24AABCI3632E1Z3 (Gujarat), 24AABCI3632E2Z2 (Gujarat), 29AABCI3632E1ZT (Karnataka).
The CIN (Corporate Identification Number) of Invent Bio-Med is U33110MH2005PTC152988. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Invent Bio-Med has 33 court cases on record: 4 filed by the company and 30 filed against it. 6 are pending. Most are in the district courts.
Invent Bio-Med was incorporated on 03 May 2005, making it 21+ years old. It is registered with the Registrar of Companies, Mumbai.
Invent Bio-Med has 18 deals on record (10 funding rounds, 6 secondary share transfers, 2 convertible or debt financings), with disclosed funding of ₹30.79 Cr; the latest was in September 2022.
The peers of Invent Bio-Med by revenue are Aj Fibertek India Private Limited, Advansys (India) Private Limited, Infinity Mediquip India Private Limited, Dantech Digital Dental Solutions Private Limited, all in the Healthcare industry (Medical and Laboratory Equipment), with the same principal business activity (other manufacturing including jewellery, musical instruments, medical instruments, sports goods, etc. activities).
Amit Banwarilal Agrawal ceased to be Additional Director on 30 Sep 2022. Amit Banwarilal Agrawal was appointed as Director on 16 May 2022. Nivedita Ravishankar Srivastava ceased to be Whole-Time Director on 29 Sep 2018. Invent Bio-Med has 13 board changes on record in total.
Yes, Invent Bio-Med is registered as a small enterprise under Udyam registration (number: UDYAM-MH-18-0029165).
Invent Bio-Med has 13 MSME Form 1 returns on record between 2017 and 2021, listing 49 overdue payments to 3 micro and small suppliers. The latest return was filed on 05 Aug 2021.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages